The Potassium Supplementation Study
Running, not enrolling · Not applicable · Has a placebo group
Conditions studied: Cardiovascular Health, Cardiovascular Risk Factor
In brief
This study will test whether potassium supplementation can reduce the deleterious effect of a high sodium diet on blood vessel function, blood pressure reactivity and autonomic nervous system function in apparently healthy adults.
Key facts
- Study ID
- NCT05887622
- Run by
- University of Delaware
- People needed
- 30
- Starts
- 2022-01-24
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-05-05
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- men and women
- 18-45 years of age
- all races/ethnicities
- BMI < 30 kg/m2
- BP < 130/80 mmHg
You may not qualify if…
- presence of hypertension
- known heart disease
- diabetes
- kidney disease
- cancer
- inflammatory conditions
- blood clotting disorders
- pregnancy
- adrenal gland disorder
- history of stomach or intestinal bleeding
- history of kidney stones
- serum potassium outside of the normal range
Where it is running
- Tower at STAR — Newark, Delaware, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.